Anil Kumar
40Patents
9h-index
54Co-inventors
78Inventor score
Filing activity: Apr 5, 1993 → Nov 4, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5807861A | Amine substituted xanthinyl compounds | Chemistry; Metallurgy | 73 | Expired |
| US5670506A | Halogen, isothiocyanate or azide substituted xanthines | Chemistry; Metallurgy | 33 | Expired |
| US5807862A | Therapeutic compounds containing pyrimidinyl moieties | Chemistry; Metallurgy | 30 | Expired |
| US5641783A | Substituted amino alcohol compounds | Chemistry; Metallurgy | 27 | Expired |
| US5801182A | Amine substituted compounds | Chemistry; Metallurgy | 27 | Expired |
| US6878715B1 | Therapeutic compounds for inhibiting interleukin-12 signals and method for using same | Chemistry; Metallurgy | 25 | Expired |
| US5837703A | Amino-alcohol substituted cyclic compounds | Chemistry; Metallurgy | 25 | Expired |
| US6020337A | Electronegative-substituted long chain xanthine compounds | Chemistry; Metallurgy | 19 | Expired |
| US5629423A | Asymmetric synthesis of chiral secondary alcohols | Chemistry; Metallurgy | 12 | Expired |
| US6469017B1 | Method of inhibiting interleukin-12 signaling | Chemistry; Metallurgy | 9 | Expired |
| US7291616B2 | Aryl triazines as LPAAT-β inhibitors and uses thereof | Chemistry; Metallurgy | 9 | Expired |
| US5777117A | Method for preparing substituted amino alcohol compounds | Chemistry; Metallurgy | 9 | Expired |
| US5756511A | Method for treating symptoms of a neurodegenerative condition | Human Necessities | 8 | Expired |
| US6774130B2 | Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same | Chemistry; Metallurgy | 8 | Expired |
| US6075029A | Xanthine modulators of metabolism of cellular P-450 | Chemistry; Metallurgy | 8 | Expired |
| US7618968B2 | Aryl triazines as LPAAT-β inhibitors and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US6103730A | Amine substituted compounds | Chemistry; Metallurgy | 6 | Expired |
| US6100271A | Therapeutic compounds containing xanthinyl | Chemistry; Metallurgy | 6 | Expired |
| US6780865B1 | Compounds having selective hydrolytic potentials | Chemistry; Metallurgy | 6 | Expired |
| US6043250A | Methods for using therapeutic compounds containing xanthinyl | Chemistry; Metallurgy | 6 | Expired |
| US6693105B1 | Hydroxyl-containing compounds | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5521315A | Olefin substituted long chain compounds | Human Necessities | 4 | Expired |
| US5866576A | Epoxide-containing compounds | Chemistry; Metallurgy | 3 | Expired |
| US10208030B2 | GPR119 agonist compounds | Chemistry; Metallurgy | 2 | Active |
| US9169255B2 | Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.